Buckland Martin

Chief Business Officer at Astex Pharmaceuticals, Inc · on record since Jul 22, 2011

Insider trading activity of Buckland Martin

Transactions on record: 19; since Jul 22, 2011

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Oct 16, 2013

Figures computed from official regulatory filings — .

Companies where Buckland Martin has traded

Astex Pharmaceuticals, Inc19 tx · Oct 16, 2013

Track record of Buckland Martin

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Buckland Martin

Co-insiders of Buckland Martin

AZAB MOHAMMADAstex Pharmaceuticals, Inc
Bearss DavidAstex Pharmaceuticals, Inc
Berk GregoryAstex Pharmaceuticals, Inc
BIOTECHNOLOGY VALUE FUND II LPAstex Pharmaceuticals, Inc
BIOTECHNOLOGY VALUE FUND L PAstex Pharmaceuticals, Inc
BVF INC/ILAstex Pharmaceuticals, Inc
BVF INVESTMENTS LLCAstex Pharmaceuticals, Inc
BVF PARTNERS L P/ILAstex Pharmaceuticals, Inc
CASAMENTO CHARLES JAstex Pharmaceuticals, Inc
Fellner PeterAstex Pharmaceuticals, Inc
GIRARDI THOMAS VAstex Pharmaceuticals, Inc
Goldberg Allan RAstex Pharmaceuticals, Inc
Haines TimothyAstex Pharmaceuticals, Inc
Hansen ChristianAstex Pharmaceuticals, Inc
JACOBS EDWARD LAstex Pharmaceuticals, Inc
JAKUBOWSKI AUDREY FAstex Pharmaceuticals, Inc
Jhoti HarrenAstex Pharmaceuticals, Inc
Kola IsmailAstex Pharmaceuticals, Inc
LACK WALTER JAstex Pharmaceuticals, Inc
LAMPERT MARK NAstex Pharmaceuticals, Inc
MANUSO JAMES S JAstex Pharmaceuticals, Inc
METTINGER KARL LAstex Pharmaceuticals, Inc
MOLKENTIN MICHAELAstex Pharmaceuticals, Inc
NB Public Equity K/SAstex Pharmaceuticals, Inc
ROSENFELD CRAIG SAstex Pharmaceuticals, Inc
RUBINFELD JOSEPHAstex Pharmaceuticals, Inc
Schonharting FlorianAstex Pharmaceuticals, Inc
YOUNG MICHAEL DAstex Pharmaceuticals, Inc

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	OtherD (derivative)	-19,644	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	OtherD (derivative)	-26,192	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	OtherD (derivative)	-52,384	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	OtherD (derivative)	-26,192	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	OtherD (derivative)	-98,220	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	OtherD (derivative)	-180,000	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	OtherD (derivative)	-32,085	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	OtherD (derivative)	-150,000	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	OtherD (derivative)	-180,000	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	Other	-5,963	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Dec 10, 2012	AwardD (derivative)	180,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Astex Pharmaceuticals, IncListing unverified	Mar 9, 2012	AwardD (derivative)	180,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Astex Pharmaceuticals, IncListing unverified	Sep 20, 2011	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Astex Pharmaceuticals, IncListing unverified	Jul 22, 2011	AwardD (derivative)	26,192	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Jul 22, 2011	AwardD (derivative)	98,220	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Jul 22, 2011	AwardD (derivative)	32,085	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Jul 22, 2011	AwardD (derivative)	19,644	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Jul 22, 2011	AwardD (derivative)	26,192	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Jul 22, 2011	AwardD (derivative)	52,384	—	n/a (No price was disclosed in the filing)	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	OtherD (derivative)	-19,644	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	OtherD (derivative)	-26,192	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	OtherD (derivative)	-52,384	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	OtherD (derivative)	-26,192	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	OtherD (derivative)	-98,220	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	OtherD (derivative)	-180,000	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	OtherD (derivative)	-32,085	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	OtherD (derivative)	-150,000	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	OtherD (derivative)	-180,000	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Oct 16, 2013	Other	-5,963	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Dec 10, 2012	AwardD (derivative)	180,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Astex Pharmaceuticals, IncListing unverified	Mar 9, 2012	AwardD (derivative)	180,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Astex Pharmaceuticals, IncListing unverified	Sep 20, 2011	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Astex Pharmaceuticals, IncListing unverified	Jul 22, 2011	AwardD (derivative)	26,192	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Jul 22, 2011	AwardD (derivative)	98,220	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Jul 22, 2011	AwardD (derivative)	32,085	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Jul 22, 2011	AwardD (derivative)	19,644	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Jul 22, 2011	AwardD (derivative)	26,192	—	n/a (No price was disclosed in the filing)	SEC
Astex Pharmaceuticals, IncListing unverified	Jul 22, 2011	AwardD (derivative)	52,384	—	n/a (No price was disclosed in the filing)	SEC